Research programme: ion channel modulators - Hydra Biosciences

Drug Profile

Research programme: ion channel modulators - Hydra Biosciences

Alternative Names: HC-030031; HC-045314; TRPBH 1; TRPBH 2; TRPBH 3; TRPHB1; TRPHB2

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Hydra Biosciences
  • Class Small molecules
  • Mechanism of Action CATSPER ion channel modulators; Ion channel modulators; TRPA1 protein inhibitors; TRPV cation channel antagonists; TRPV cation channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Asthma; Hypertension; Inflammation; Kidney disorders; Lung disorders; Osteoporosis; Overactive bladder; Pain

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Asthma in USA
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Hypertension in USA
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top